ZNF227 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.594400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.486800E-01
Normal-vs-Stage2
2.235400E-01
Normal-vs-Stage3
1.690800E-01
Normal-vs-Stage4
9.672200E-01
Stage1-vs-Stage2
3.198000E-01
Stage1-vs-Stage3
1.694150E-01
Stage1-vs-Stage4
7.182400E-01
Stage2-vs-Stage3
2.158600E-01
Stage2-vs-Stage4
1.799210E-01
Stage3-vs-Stage4
6.864400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.720800E-01
Normal-vs-AfricanAmerican
5.186400E-01
Normal-vs-Asian
1.293560E-01
Caucasian-vs-AfricanAmerican
7.515600E-01
Caucasian-vs-Asian
1.561420E-01
AfricanAmerican-vs-Asian
2.463200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.897400E-01
Normal-vs-Female
2.420200E-01
Male-vs-Female
7.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.202200E-01
Normal-vs-Age(41-60Yrs)
5.911000E-01
Normal-vs-Age(61-80Yrs)
1.677380E-01
Normal-vs-Age(81-100Yrs)
2.975800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.612000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.143580E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.556200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.799000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.172200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.347700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.710000E-02
Normal-vs-Daily Drinker
2.163800E-01
Normal-vs-Weekly Drinker
1.325040E-01
Normal-vs-Occasional Drinker
5.891200E-01
Normal-vs-Social Drinker
4.502200E-01
Non Drinker-vs-Daily Drinker
5.730600E-01
Non Drinker-vs-Weekly Drinker
8.397400E-01
Non Drinker-vs-Occasional Drinker
1.203850E-02
Non Drinker-vs-Social Drinker
1.547610E-01
Daily Drinker-vs-Weekly Drinker
5.348000E-01
Daily Drinker-vs-Occasional Drinker
8.206200E-02
Daily Drinker-vs-Social Drinker
4.115600E-01
Weekly Drinker-vs-Occasional Drinker
2.410300E-02
Weekly Drinker-vs-Social Drinker
1.937180E-01
Occasional Drinker-vs-Social Drinker
4.652000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.237160E-01
Normal-vs-Grade 2
2.122100E-02
Normal-vs-Grade 3
2.736300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.267600E-01
Grade 1-vs-Grade 3
8.092000E-01
Grade 1-vs-Grade 4
1.237160E-01
Grade 2-vs-Grade 3
3.480600E-01
Grade 2-vs-Grade 4
2.122100E-02
Grade 3-vs-Grade 4
2.736300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.389800E-02
Normal-vs-NonDiabetic
2.936800E-01
Diabetic-vs-NonDiabetic
2.997900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.389960E-01
Normal-vs-NoPancreatitis
2.148000E-01
Pancreatitis-vs-NoPancreatitis
4.641400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.208000E-01
Normal-vs-N1
2.341200E-01
N0-vs-N1
8.360000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.392600E-01
Normal-vs-TP53-NonMutant
5.678400E-01
TP53-Mutant-vs-TP53-NonMutant
7.312400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
